Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Head & Neck 1Breast 1

Conditions

Xerostomia 1Sexuality 1Sexual Dysfunction, Physiological 1Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Pilocarpine × Clear all
NCT00343382 2016-08-12

Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
201 enrolled 11 charts
BreastOther

Breast Neoplasms, Sexual Dysfunction, Physiological, Sexuality

NCT00168181 2011-04-18

Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients

AHS Cancer Control Alberta

Phase 3 Completed
220 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms, Xerostomia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡